Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Jade Biosciences, Inc.
Market Cap
$823.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$838.62M
Interest Coverage Ratio
-80.18x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$850.77M
Interest Coverage Ratio
-5.18x
TTM Avg
6.05x
3Y Avg
536.48x
5Y Avg
359.36x
Market Cap
$841.98M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$846.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$797.70M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $823.43M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | -80.18x | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $809.02M | -1.44x | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $850.77M | -5.18x | 6.05x | 536.48x | 359.36x |
| InMode Ltd. (INMD)vs › | $805.59M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $841.98M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $846.87M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $848.46M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $797.70M | N/A | 85.72x | 85.72x | 85.72x |
| Apnimed, Inc. (APMD)vs › | $790.49M | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
0.00
Current Ratio
14.93
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
